Joshua Chu is Executive Vice President of Vaccines and Cancer at the Clinton Health Access Initiative (CHAI). He is responsible for CHAI’s work to accelerate the introduction of new vaccines, improve implementation of national immunization strategies and lower the prices of essential vaccines and cold chain equipment. He also oversees CHAI’s work in cancer and will be leading the development and launch of new programs in diabetes and cardiovascular diseases.
Mr. Chu joined CHAI in 2009. Prior to assuming his current roles, he first served as Deputy Country Director in Nigeria and then as Regional Director of Southeast Asia. During his tenure in Nigeria, CHAI expanded its scope to include new programs in vaccines, family planning, essential treatments for diarrhea, and human resources for health. As Regional Director, he oversaw the development of new programs in the region which includes Cambodia, Indonesia, Laos, Myanmar, Papua New Guinea, and Vietnam.
Prior to joining CHAI, Mr. Chu held several roles including managing Singapore Airlines’ multi-billion-dollar investment portfolio of companies in Europe, Asia, and Oceania. In addition, he has held consulting and operational roles with various organizations in China, Kazakhstan, United States, and Zambia.
Mr. Chu obtained his Bachelor of Science in Economics and Bachelor of Arts in Middle Eastern and Asian studies (summa cum laude) from the Wharton School, University of Pennsylvania. He later obtained a Mphil in Development Studies (with distinction) from St Johns’ College, University of Cambridge, as a Maxis scholar.